Entity information:
NOTE
11
 
- INCOME TAXES
 
The Company accounts for income taxes in accordance with FASB ASC Topic
740,
Accounting for Income Taxes; which requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting and any available operating loss or tax credit carry forwards. The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company
’s future earnings, and other future events, the effects of which cannot be determined. In accordance with prevailing accounting guidance, the Company is required to recognize and disclose any income tax uncertainties. The guidance provides a
two
-step approach to recognizing and measuring tax benefits and liabilities when realization of the tax position is uncertain. The
first
step is to determine whether the tax position meets the more-likely-than-
not
condition for recognition and the
second
step is to determine the amount to be recognized based on the cumulative probability that exceeds
50%,
Actual results could differ from these estimates.
 
As of
December 31,
201
7,
the Company had net operating loss carryovers of approximately
$13,683,343
for U.S. federal tax purposes expiring through
2037;
approximately
$6,517,915
for Danish tax purposes, which do
not
expire; approximately
$499,020
for German tax purposes, which do
not
expire and approximately
$648,358
for Singapore tax purposes which do
not
expire.
 
As of
December 31, 2017
and
December 31, 2016,
the Company established a valuation allowance of
$2,833,000
and
$3,542,000
for the tax components of LiqTech International Inc. and Liqtech NA, respectively,
$1,850,000
and
$1,095,000
for the tax components of LiqTech International AS and LiqTech Systems, respectively,
$139,000
and
$122,000
for the tax component of LiqTech Germany and
$110,000
and
$97,000
for the tax component of LiqTech Singapore as management could
not
determine that it was more than likely
not
that sufficient income could be generated by these components to realize the resulting net operating loss carry forwards and other deferred tax assets of these components.
The change in the valuation allowance for the year ended
December 31, 2017
was $(
709,000
),
$755,000,
$17,000
and
$13,000
for the US, Danish, German and Singapore components. The change in the valuation allowance for the year ended
December 31, 2016
was
$3,542,000
,
$1,095,000,
$4,000
and
$12,000
for the US, Danish, German and Singapore components.
 
The Company is
not
relying on the reversal of deferred tax liabilities to realize the deferred tax assets. The same variable used by the Company in evaluating goodwill for impairment were used in assessing the realization of deferred tax assets (See Note
7
).
 
The temporary differences, tax credits and carry forwards gave rise to the following deferred tax asset (liabilities) at
December 31,
201
7
and
December 31, 2016:
 
   
2017
   
2016
 
Vacation accrual
  $
2,900
    $
5,450
 
Allowance for doubtful accounts
   
743
     
1,202
 
Reserve for obsolete inventory
   
305,425
     
200,118
 
Business tax credit carryover
   
30,935
     
30,935
 
Deferred Compensation
   
16,787
     
8,500
 
Net operating loss carryover
   
4,646,434
     
4,906,974
 
Excess of book over tax depreciation
   
(71,116
)
   
(296,227
)
Valuation allowance
   
(4,932,108
)
   
(4,856,952
)
Long term deferred tax asset
  $
-
    $
-
 
 
A reconciliation of income tax expense at the federal statutory rate to income tax expense at the Company
’s effective rate is as follows for the years ended 
December 31, 2017
and
2016:
 
 
   
2017
   
2016
 
Computed tax at expected statutory rate
  $
(1,624,575
)
  $
(4,487,649
)
State and local income taxes, net of federal benefit
   
(4,350
)    
(3,721
)
Non-US income taxed at different rates
   
256,207
     
1,325,180
 
Effect of change in corporate tax rate    
994,336
     
(21,489
)
Non-deductible impairment of goodwill    
-
     
1,615,506
 
Non-deductible deferred compensation    
-
     
148,170
 
Non-deductible expenses    
4,664
     
4,242
 
Valuation allowance
   
75,156
     
4,739,806
 
Other
   
(19,248
)    
(100,368
)
Income tax expense (benefit)
  $
(317,810
)   $
3,219,677
 
 
The components of income tax expense (benefit) from continuing operations for the years ended
December 31,
201
7
and
2016
consisted of the following:
 
   
2017
   
2016
 
Current income tax expense:
               
Danish
  $
(317,810
)   $
(329,816
)
Federal
   
-
     
-
 
State
   
-
     
580
 
Current tax (benefit)
  $
(317,810
)   $
(329,236
)
                 
                 
Book in excess of tax depreciation
  $
(225,111
)   $
(158,684)
 
Allowance for doubful accounts    
459
     
12,705
 
Net operating loss carryover
   
260,540
     
(1,000,650
)
Valuation allowance
   
75,156
 
   
4,756,011
 
Deferred compensation
   
(8,287
)    
(8,500
)
Accrued vacation
   
2,550
     
(1,517
)
Reserve for obsolete inventory
   
(105,307
)    
(50,452
)
Deferred tax expense (benefit)
  $
-
    $
3,548,913
 
Total tax expense (benefit)
  $
(317,810
)   $
3,219,677
 
 
Deferred income tax expense / (benefit) results primarily from the reversal of temporary timing differences between tax and financial statement income.
 
 
 
The Company files Danish and U.S. federal and
 Minnesota state income tax returns. LiqTech International AS is generally
no
longer subject to tax examinations for years prior to
2013
for their Danish tax returns. LiqTech NA is generally
no
longer subject to tax examinations for years prior to
2013
for U.S. federal and U.S. states tax returns.